0001968202-23-000046.txt : 20231206
0001968202-23-000046.hdr.sgml : 20231206
20231206160223
ACCESSION NUMBER: 0001968202-23-000046
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231204
FILED AS OF DATE: 20231206
DATE AS OF CHANGE: 20231206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MURPHY ANDREW J
CENTRAL INDEX KEY: 0001796226
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 231469591
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2023-12-04
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001796226
MURPHY ANDREW J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Research
1
Common Stock
2023-12-04
4
M
0
20000
270.43
A
79421
D
Common Stock
2023-12-04
4
F
0
13464
813.58
D
65957
D
Common Stock
2023-12-05
4
S
0
136
810.38
D
65821
D
Common Stock
2023-12-05
4
S
0
103
811.37
D
65718
D
Common Stock
2023-12-05
4
S
0
372
812.57
D
65346
D
Common Stock
2023-12-05
4
S
0
167
813.66
D
65179
D
Common Stock
2023-12-05
4
S
0
58
814.06
D
65121
D
Common Stock
2023-12-05
4
S
0
155
815.97
D
64966
D
Common Stock
2023-12-05
4
S
0
829
816.46
D
64137
D
Common Stock
2023-12-05
4
S
0
1881
817.36
D
62256
D
Common Stock
2023-12-05
4
S
0
1333
818.59
D
60923
D
Common Stock
2023-12-05
4
S
0
973
819.57
D
59950
D
Common Stock
2023-12-05
4
S
0
345
820.54
D
59605
D
Common Stock
2023-12-05
4
S
0
184
821.46
D
59421
D
Common Stock
4310
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
270.43
2023-12-04
4
M
0
20000
0.0
D
2023-12-13
Common Stock
20000
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 9, 2023.
Represents volume-weighted average price of sales of 372 shares of Company stock on December 5, 2023 at prices ranging from $812.26 to $812.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Represents volume-weighted average price of sales of 167 shares of Company stock on December 5, 2023 at prices ranging from $813.00 to $813.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Represents volume-weighted average price of sales of 155 shares of Company stock on December 5, 2023 at prices ranging from $815.90 to $815.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Represents volume-weighted average price of sales of 829 shares of Company stock on December 5, 2023 at prices ranging from $816.01 to $816.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Represents volume-weighted average price of sales of 1,881 shares of Company stock on December 5, 2023 at prices ranging from $817.04 to $817.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Represents volume-weighted average price of sales of 1,333 shares of Company stock on December 5, 2023 at prices ranging from $818.07 to $818.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Represents volume-weighted average price of sales of 973 shares of Company stock on December 5, 2023 at prices ranging from $819.03 to $819.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Represents volume-weighted average price of sales of 345 shares of Company stock on December 5, 2023 at prices ranging from $820.27 to $820.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Represents volume-weighted average price of sales of 184 shares of Company stock on December 5, 2023 at prices ranging from $821.39 to $821.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Andrew Murphy
2023-12-06